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Abstract
Background: Congenital cytomegalovirus (CMV) brain infection causes serious neuro-developmental sequelae including:
mental retardation, cerebral palsy, and sensorineural hearing loss. But, the mechanisms of injury and pathogenesis to the
fetal brain are not completely understood. The present study addresses potential pathogenic mechanisms by which this
virus injures the CNS using a neonatal mouse model that mirrors congenital brain infection. This investigation focused on,
analysis of cell types infected with mouse cytomegalovirus (MCMV) and the pattern of injury to the developing brain.
Methodology/Principal Findings: We used our MCMV infection model and a multi-color flow cytometry approach to
quantify the effect of viral infection on the developing brain, identifying specific target cells and the consequent effect on
neurogenesis. In this study, we show that neural stem cells (NSCs) and neuronal precursor cells are the principal target cells
for MCMV in the developing brain. In addition, viral infection was demonstrated to cause a loss of NSCs expressing CD133
and nestin. We also showed that infection of neonates leads to subsequent abnormal brain development as indicated by
loss of CD24(hi) cells that incorporated BrdU. This neonatal brain infection was also associated with altered expression of
Oct4, a multipotency marker; as well as down regulation of the neurotrophins BDNF and NT3, which are essential to
regulate the birth and differentiation of neurons during normal brain development. Finally, we report decreased expression
of doublecortin, a marker to identify young neurons, following viral brain infection.
Conclusions: MCMV brain infection of newborn mice causes significant loss of NSCs, decreased proliferation of neuronal
precursor cells, and marked loss of young neurons.
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Introduction
Cytomegalovirus (CMV) is the most common infectious cause of
developmental disorders of the central nervous system (CNS) in
humans and the predominant cause of developmental neurological
disabilities in the United States [1]. Each year, approximately 1%
of all newborns have congenital CMV infection. Approximately 5
to 10% of these infected infants manifest signs of serious
neurological defects at birth, including deafness, mental retarda-
tion, blindness, microencephaly, hydrocephalus, and cerebral
calcification [2,3,4]. Thus, it seems likely that CMV infection of
the fetus alters the ‘‘normal blueprint’’ of the developing brain,
resulting in long-term neurological sequelae.
Using a murine infection model, we have previously shown that
NSCs in the adult brain appear to be the predominant cell type
affected by murine cytomegalovirus (MCMV) [5]. There is an
abundance of NSCs in the fetal brain, in this study we will use the
term neural stem cells to refer to all classes of immature and
proliferating cells that reacted with CD133 and nestin. The
susceptibility of these cells to viral infection could provide insights
into the neuropathogenesis of CMV during brain development [6].
Previous studies have shown that MCMV can infect a wide variety of
brain cell types including neurons and astrocytes [7]. These studies
used immunohistochemical staining to demonstrate co-localization of
viral antigens and cell type-specific markers. However, there is a
paucity of data quantifying the effect of MCMV infection on the
developing brain and which cell types involved.
Recent advances in the identification of specific neural cell types
based on cellsurfaceand intracellularmarkers,usingflow cytometry,
have lead to detailed characterization of neural stem and progenitor
cells, as well as their down-stream progeny. Cell surface markers
such as CD133, CD15, CD24, and CD29 have been used in a
number of recently published studies [8,9,10]. These studies indicate
that human CNS precursor cells expressing high levels of the surface
antigen CD133 (CD133+/hi), with little or no CD24 (CD242/lo),
have the highest frequency of initiating clones as measured by
neurosphereformation[11,12].Evidencesuggeststhatthesemarkers
are also useful for characterizing similar subpopulations from the
rodent CNS [13,14]. In fact, high CD24 expression has been used to
identify transit-amplifying cells [15], as well as differentiated neurons
[16], and CD24 is required for terminal differentiation of neuronal
progenitors [17]. Another commonly used marker is CD29, a
member of the integrin family. These integrins play an important
role in neural development [18], and CD29 specifically has been
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addition, integrin signaling has been shown to be of functional
relevance for both neural crest [20] and mesenchymal development
[21,22]. Finally, the antigen CD15, also known as LeX or stage-
specific embryonic antigen 1 (SSEA1), has been identified as a
positive selectable marker for rodent multipotent NSCs [23].
In this study we used our MCMV infection model and a multi-
color flow cytometry approach to quantify the effect of MCMV on
the developing brain, identifying specific target cells for viral
infection and its effect on subsequent brain development. Our
findings indicate that NSCs expressing CD133 and nestin are the
prime target cells along with CD24(hi) neuroblasts. We also show
that infection of the developing brain, which is rich in NSCs,
results in reduced expression of doublecortin (DCX), a marker that
identifies young/immature neurons, while the glial precursor and
mature astrocyte marker, glial acidic fibrillary protein (GFAP)
expression remained unaltered. Reduced DCX expression was
also associated with decreased neurotrophin expression. Taken
together, these results demonstrate markedly abnormal neuronal
development following MCMV brain infection.
Results
CD133(+) cells are infected with MCMV in vivo
We have previously shown that MCMV can establish
productive infection in cells which express nestin [5]. In the
present study, MCMV infection of NSCs was further character-
ized in vivo. CD133(+) cells have previously been shown to be
having highest frequency of initiating clones as measured by
neurosphere formation [11]. We first examined if CD133(+) cells
were targets for viral infection by using a recombinant MCMV
expressing GFP. One-day old neonates were infected with MCMV
and control littermates were mock-infected. Brain tissues from
infected and mock-infected animals were harvested at 7 d p.i. for
analysis by flow cytometry. Harvested brain tissue samples were
digested into single cell suspension using papain as described in the
methods. One million cells from infected or mock-infected mice
were incubated with APC conjugated CD133 MAbs and analyzed
by flow cytometry for CD133(+) cells that expressed GFP,
indicating virus-infected cells. Flow cytometry analysis (Fig 1A)
showed the ratio of CD133(+) cells in a P7 (post-natal day 7) brain
(3.9362.13%). We then identified GFP(+) cells that demonstrated
viral infection within this CD133(+) population. We observed
65.9763.1% of CD133+ cells were positive for GFP at 7 d p.i.
(Fig. 1B). Approximately 5–6% of the total brain cells were
positive for GFP (indicative of infected cells) at 7 d p.i.
NSCs expressing nestin are targets for MCMV
To reinforce our previous finding that MCMV preferentially
infects stem cells [5], we next investigated MCMV infection in the
neonatal brain, which has previously been shown to be rich in
NSCs. We identified virus-infected cells using intracellular staining
for the neuralstem marker, nestin.Cells prepared from the brains of
infectedandcontrolanimalswerestainedfornestinand analyzed by
flowcytometry. Flow cytometryanalysisat 7 d p.i. demonstrated the
presence of nestin(+) and nestin(2) cells from mock-infected mice
(Fig 2, lower panel). There was no significant difference in the ratio
of nestin (2) cells from the mock- and MCMV-infected brains. The
nestin(2) and nestin(+) populations were then examined for the
presence of GFP, indicative of viral infection (Fig 2, upper panel).
These data clearly show that a significantly higher proportion of
nestin(+) cells were found to be infected with MCMV, when
compared to nestin(2) cells (26.1262.3% versus 8.1461.5%).
MCMV brain infection reduces CD133(+) cell number and
alters nestin expression
Because NSCs were found to be infected with MCMV, we then
assessed whether viral infection had any effect on their number.
Brain tissues were harvested from MCMV-infected and non-
infected control neonates at 7 d p.i. and were stained for CD133.
Flow cytometric analysis showed that numbers of CD133(+) cells
were significantly reduced in the infected brains (1.4160.80%)
when compared to controls (5.3562.0%) (Fig 3A). Absolute
numbers of CD133(+) cells in control and MCMV-infected mice
Figure 1. CD133(+) cells are infected with MCMV in the developing brain. A. Day-old neonates from timed breeders were infected intra-
cerebrally (i.c.) either with 200 TCID50 of virulent, salivary gland passed recombinant MCMV expressing green fluorescent protein (GFP) or with mock
inoculum, representing controls. A single cell suspension was prepared from the harvested brains by papain enzyme digestion at 7 d p.i. One million
cells from both infected and control brains were stained for CD133, and analyzed by flow cytometry. B. Representative histogram showing MCMV
infected CD133(+) cells, the black line represents control and the green line was obtained from MCMV-infected brain. Data shown are representative
of three independent experiments using cells prepared from P7 brains obtained from 4, 3 and 5 neonates, respectively.
doi:10.1371/journal.pone.0016211.g001
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564.1610
4 and 3.45610
462.1610
4, p=0.01 (Fig 3
B). Relatively low levels of nestin expression were detected in
infected-brains by flow cytometry (Fig 3C). Mean fluorescence
intensity of nestin expression was found to be significantly lower
among cells purified from virus-infected neonates (57.0062.2%
versus 143.0062.84%, respectively, p,0.01 Student’s t test)
(Fig. 3D).
CD24(hi)-expressing neuronal precursor cells were
targets for MCMV
To further characterize cell types infected in the developing
brain, we identified cellular subsets based on their surface cluster
of differentiation (CD). Previously described studies that have used
CD15, CD24, and CD29 to identify various neural progenitors
derived from embryonic stem cells formed the basis for our study
[24]. High CD24 expression has been used to identify transit-
amplifying cells [15], as well as differentiated neurons [16], and
CD24 is required for terminal differentiation of neuronal
progenitors [17]. The antigen CD15, also known as LeX or
stage-specific embryonic antigen 1 (SSEA1), has also been
identified as a positive selectable marker for rodent multipotent
NSCs [23]. We went on to prepare cells from brains of virus-
infected and control animals, incubated them with CD15, CD24,
CD29 and CD45 MAbs, and analyzed by flow cytometry. The
Figure 2. Neural stem/progentior cells (NSPC) expressing nestin are targets for MCMV. Representative dotplot showing nestin(+)/
nestin(2) cells from P7 brain. Day-old neonates were infected through intra-cerebral injections with 200 TCID50 of recombinant virus expressing GFP
and control neonates received similar dose of mock inoculum. Brain tissues from infected and control animals were harvested at 7 d p.i., and
dissociated into single cells using TrypLE enzyme. The cells were stained for intracellular nestin and analyzed for nestin(2)GFP(+) as well as
nestin(+)GFP(+) cells. Gates in the histograms were drawn based on mock-infected controls. Data shown are representative of three independent
experiments using cells prepared from P7 brains (n=12 neonates).
doi:10.1371/journal.pone.0016211.g002
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prepared from control mice, depicting three distinct cellular
subsets, CD24(hi)CD29(2), CD24(hi)CD29(+) and CD24(lo)
CD29(2). Gates were drawn based on the individual flurochromes
and isotype control analyses. All of these subsets were negative for
CD15 and CD45, indicating these subpopulations were devoid of
NSCs and infiltrating immune cells, respectively. The top panels
display histogram overlays from control and infected mice,
showing respective GFP positive cells from each group.
CD24(hi)CD29(2) cells had approximately 38.1363.4% positive
for GFP signal at 7 d p.i., while the CD24(hi)CD29(+) cells showed
8.162.2% of cells positive for virus. The CD24 (lo) CD29 (2)
population did not show any detectable virus-infected cells, hence
they were excluded from further analysis.
Reduced numbers of proliferative CD24(hi) neuronal
precursor cells in infected brains
CD24isexpressed byprecursorsofneuronalcellsinthedeveloping
brain [16] and by neuroblasts from two adult neurogenic zones: the
subventricular zone (SVZ) bordering the lateral ventricle, and the
dentate gyrus of the hippocampal formation [25]. Weinvestigated the
effect of virus infection on proliferation of CD24(hi) cells. Single cells
prepared from brains harvested from bromodeoxyuridine (BrdU)-
treated mice were first stained for surface markers such as CD24,
CD29, and CD45. Intranuclear BrdU staining was done using a
BrdU flow kit asdescribed in the methods,and cells wereanalyzed by
flow cytometry. The individual subsets of cells that were previously
defined were analyzed for BrdU+ (Fig. 5A). In these studies, we
observed a significant decrease in the number of CD24(hi)
Figure 3. Viral infection reduces the number of CD133(+) cells and alters nestin expression in the developing brain. A. Representative
dotplots from mock-infected and MCMV-infected brains showing CD133(+) cells at 7 d p.i. Dissociated brain-derived cells were incubated with
CD133(+) Mabs and analyzed by flow cytometry. Live cell gating was performed by using 7 AAD, the live cells were also excluded from immune cells
that may infiltrate during the infection using CD45-PE-Cy5. B. The absolute numbers of CD133(+) cells obtained from infected brains versus control
brains are shown. Data were derived from 3 independent experiments, n=3–5 neonates. *p,0.05 versus mock infected. The cells prepared from P7
brain were also stained for intracellular nestin expression. C. Representative histogram overlays from isotype (grey line, filled) uninfected (red line,
tinge) and infected (blue line) brains. D. Mean fluorescent intensity for nestin expression was calculated and found to be significantly lower in the
cells isolated from virus-infected brain. Data were derived from 3 independent experiments, n=3–5 neonates. *p,0.05 versus control new born mice.
doi:10.1371/journal.pone.0016211.g003
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control mice (2.81610
466.2610
3 and 1.73610
465.3610
36
5.3610
3 versus 1.68610
566.9610
4 and 2.7610
569.3610
4 in
control animals, respectively, p,0.01 Student’s t test) (Fig. 5B).
Altered expression of the Oct4 transcription factor
Oct4 is critically involved in self-renewal of embryonic stem
cells, so it is frequently used as a marker for undifferentiated cells.
Oct4 expression must be closely regulated; too much or too little
Figure 4. CD24(hi), neuronal precursors cells are infected with the virus. We first established a surface biomarker code based on published
literature to identify the types of cells that were infected with MCMV. Brain-derived cells prepared from either infected or mock-infected animals were
incubated with different Mabs for surface markers including CD15, CD24 and CD29. Representative contour plot prepared from control mice, gated
on the CD45(2)CD15(2) population showing the classification of cells (lower panel) and the ratio of MCMV-GFP(+) among the subtypes are shown
(upper panel). CD24 expression in the developing brain has been attributed to transit amplifying cells and is also required for terminal differentiation
of neuronal progenitors. High CD29 expression is associated with neural crest like progenitor cells. Three different subtypes of cells were identified
using CD24 and CD29 surface markers as shown in the representative contour plot. CD24(hi)CD29(2), CD24(hi)CD29(+) cell types were found to be
infected.
doi:10.1371/journal.pone.0016211.g004
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Sox2, and Nanog are capable of inducing the expression of each other,
and are essential for maintaining the self-renewing undifferentiated
state of the inner cell mass of the blastocyst, as well as in embryonic
stem cells [27]. It has been previously shown that CD24 cells express
Sox2 indicating they still retain stemness [28]. To determine if
CD24(hi) cells from the developing brain expressed Oct4, we
performed intracellular staining for Oct4 as well as surface stained
for CD15, CD24 and CD29 and analyzed these cell populations using
flow cytometry. In this study, we demonstrated that CD24(hi)CD29(2)
and CD24(hi)CD29(+) cells, isolated from uninfected control brains,
expressed Oct4 (Fig. 6, upper panel, histogram with blue line).
Although CD24(hi)CD29(2) negative cells were found to express
Oct4, it appeared that once CD29 expression occurred on these
CD24(hi) cells the number of Oct4-expressing cells was reduced (Fig. 6,
upper panel, histogram on the right). We then went on to determine if
MCMV infection had any effect on Oct4 expression among this
defined subset of cells. The upper panel shows histogram overlays for
Oct4 staining from brain cells isolated from control and infected brains,
as well as isotype control staining. Data obtained from these
experiments demonstrated that Oct4 expression was reduced in cells
obtained from virus-infected brains compared to the cells from the
brains of uninfected animals (upper panel, histogram overlays).
Expression of doublecortin is decreased following MCMV
brain infection
We next examined if viral infection is associated with abnormal
expression of structural proteins such as doublecortin (DCX) and
GFAP. DCX is a microtubule associated protein expressed by
neuroblasts and is accepted as an effective read-out for
neurogenesis. GFAP is an intermediate filament protein that is
thought to be specific for astrocytes. Using an intracellular staining
technique and flow cytometry, we found that expression of DCX is
altered in the virus-infected brain (Fig. 7A), while GFAP
expression remained unaltered (Fig. 7B). Histogram overlays are
shown for both DCX and GFAP expression and were prepared
from isotype, control, and virus infected peaks. Mean fluorescence
intensity of DCX and GFAP expression were also measured
between the groups. Expression levels of DCX in virus-infected
brains were found to be significantly lower compared to uninfected
control animals (5116140% versus, 11786161% respectively,
p,0.05 Student’s t test) and there was no significant difference in
the MFI of GFAP expression among groups studied (Fig. 7C).
Viral brain infection down-regulates BDNF and NT3 levels
Brain-derived neurotrophic factor (BDNF) and neurotrophin 3
(NT3) have been shown to play a role in the development of the
Figure 5. Reduced BrdU uptake by high CD24 expressing neuronal precursor cells in virus-infected brains. Mice were treated with
BrdU on 7 d p.i. and 24 h later the brain samples were collected and processed for intranuclear BrdU staining as described in the methods. Cells were
then analyzed by flow cytometry. A. Representative contour plot, gated on the CD45(2)CD15(2) population showing the classification of cells (lower
panel) and the ratio of BrdU+ cells among the respective cell types is shown (upper panel). B. The absolute numbers of BrdU+ cells within each
subtype, obtained from infected brains versus control brains are shown. Data were derived from 3 independent experiments, n=3–5 neonates.
*p,0.05 versus mock infected.
doi:10.1371/journal.pone.0016211.g005
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important in post-natal cerebellar development [29,30]. We went
on to determine mRNA levels for these two neurotrophins in
control and virus-infected brains at 7 d p.i. using quantitative real
time PCR. In these experiments, mRNA levels of both BDNF and
NT3 were markedly down-regulated in virus-infected neonatal
brains when compared to control mice (Fig. 8).
Discussion
In this study we found that NSCs and neuronal precursor cells
are the principal target cells for MCMV within the developing
brain. Additionally, viral infection caused a marked loss of NSCs
expressing CD133 and nestin. We also showed that infection of
neonatal brain leads to abnormal development as indicated by loss
of CD24 (hi) cells that incorporated BrdU. The infection of
neonatal brain was also associated with altered expression of the
neurotrophins BDNF and NT3, which are essential for normal
development of brain [29,30]. ‘‘Additionally’’ we found decreased
expression of doublecortin, a marker to identify young neurons,
following viral brain infection.
NSCs are abundant in the fetal brain and the increased
susceptibility of the fetus to viral infection may explain the
predominance of neurological damage associated with congenital
Figure 6. Differential expression of the transcription factor Oct4 in infected brains. Brain-derived cells prepared from either infected or
mock-infected animals were incubated with different MAbs for surface markers including CD15, CD24, and CD29. The cellular subsets were then
analyzed for expression of the transcription factor Oct4 and compared with mock-infected brains in the histogram overlays. Histogram overlays show
a blue line representing control neonates, an orange line MCMV infected, and a black line representing isotype for Oct4 staining. Data were derived
from 3 independent experiments, n=3–5 neonates.
doi:10.1371/journal.pone.0016211.g006
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inoculation of MCMV results in wide spread brain infection
[31,32]. In our previous report [5], we showed widespread
MCMV brain infection in adult mice, particularly in cells of the
periventricular zones as well as regions of the brain in direct
contact with cerebrospinal fluid, strikingly similar to descriptions
of human CMV (HCMV) ventriculoencephalitis in AIDS patients
and infants with severe CNS manifestations of congenital HCMV
infection. In this study, intracranial inoculation resulted in wide-
spread infection within the brain. GFP signal was detected in
various regions including cerebral cortex, olfactory bulb, cerebel-
lum and brain stem, ‘‘however’’ the infection was most profound
around the ventricles (Fig. S1). In contrast to immunocompetent
adult mice, neonates infected intracranially failed to control the
infection and succumbed to infection starting day 12 p.i. with 200
TCID50 (Fig. S2).
NSCs exhibit extensive self-renewal and multipotency (i.e., the
ability to generate neurons and glial cells). Neurogenesis continues
beyond embryonic life and postnatal and adult neurogenesis have
been postulated to have critical roles in learning, memory, and
cognitive development [33,34]. In mice, much of the brain
development takes place postnatally. Interestingly, we observed
that there was no significant difference in expression levels of
CD24 (hi) and nestin at embryonation day (ED) 14.5 and post-
natal day 7 (Fig. S3). These newborn mice also failed to mount
effective adaptive immune response and the immune infiltrate
predominantly consisted of macrophages with activated resident
microglia (Fig. S4).
Neurotropic viruses (e.g., HIV) disturb the normal adult
neurogenesis pattern, a possible cause for development of
dementia in these patients. More importantly, it has been
demonstrated that HIV infects NPCs and leads to quiescence in
these cells [35,36]. Other neurotropic viruses like Japanese
encephalitis virus (JE virus), which also targets the CNS, infects
embryonic NPCs, replicates in these cells, inhibits their growth,
and decreases proliferation [37]. Closely resembling these findings,
we report here, that MCMV infects NSCs in the developing brain
and reduces their number in vivo. Using flow cytometry, along with
a recombinant GFP-expressing MCMV, it was possible to quantify
this viral brain infection and determine the number of highly
susceptible NSCs in vivo. Our findings also indicated that CD133+
cells were the major target cells for MCMV, compared to other
cell types that were studied.
There is considerable analytical value in the identification and
isolation of multiple neural subsets by their expression of surface
antigens using flow cytometry. Fluorescence-activated cell sorting
(FACS) has been successfully utilized in sorting cells based on these
surface markers and it has high scientific value for the fields of
regenerative medicine, and stem cell biology [9,38,39]. The
combinatorial detection of surface markers by multicolor flow
cytometry has been widely applied in the fields of hematology and
immunology [40,41], but has up to now only been marginally
exploited in neurobiology [12,42]. Surface markers such as CD15,
CD24, and CD29 have been described to study neural lineage
cells derived from pluripotent stem cells [24]. Based on this
finding, we utilized the identical markers to identify cells that were
obtained from digestion of mouse brain tissue. Using these
methods, we were able to identify 3 distinct cellular populations;
CD24(hi)CD29(2), CD24(hi)CD29(+) and CD24(lo)CD29(2).
Within these subsets we identified virus-infected cells and observed
that the majority of CD24(hi) cells were infected. High CD24
expression has been used to identify transit-amplifying cells [15],
as well as differentiated neurons [16], and CD24 is required for
terminal differentiation of neuronal progenitors [17]. Infection of
CD24(hi) cells demonstrates that neuronal precursor cells are
highly susceptible to infection with MCMV. Interestingly, we were
unable to detect viral infection in cells that expressed CD24 at low
levels. It is well documented in the literature that hi CD24
Figure 7. Decreased expression of DCX in the infected brain. Cells isolated from MCMV-infected and control brains were analyzed for
intracellular doublecortin (DCX) and glial fibrillary acidic protein (GFAP) at 7 d p.i. Histogram overlays from isotype (grey line, filled), infected (blue
line, filled), and control (red line, tinge) are shown for: A. DCX, a marker for young/immature neurons and B. GFAP, a marker for glial precursors.
Infected brains showed reduced expression levels of intracellular DCX compared to control brains while there was no difference in the expression
levels of GFAP in MCMV infected versus control brains. C. Data were derived from 3 independent experiments, n=3–5 neonates. *p,0.05 versus
mock infected.
doi:10.1371/journal.pone.0016211.g007
MCMV Brain Infection Alters Neurogenesis
PLoS ONE | www.plosone.org 8 January 2011 | Volume 6 | Issue 1 | e16211expression is associated with neuronal precursor cells or
neuroblasts. Based on the available literature, it is believed that
CD24(hi)CD29(2), CD24(hi)CD29(+), and CD24(lo)CD29(2)
cells would give rise to neurons, a mixture of neurons and glia,
and identify mature neurons, respectively [24]. Our findings
indicated that neuronal precursors expressing hi CD24 are
predominant target cells for the virus. In certain cancer cell lines,
it has been shown that CD133+ cells were identified as cancer
stem cells which would also react with CD29 [43], however in our
study we did not find any such correlation between CD133 and
CD29 among the cells that we studied.
Sustained proliferation is a key feature of neural precursor cells
and it has been shown that viruses like JE virus and HIV can
induce quiescence in these cells by impairing their proliferative
ability [35,37]. Consistent with these findings, we observed that
CD24(hi)CD29(2) and CD24(hi)CD29(+) cells from control mice
were found to incorporate BrdU, with the latter subset being more
efficient. The ability of CD24(hi) cells to incorporate BrdU was
remarkably decreased in virus-infected brains, suggesting that
MCMV inhibits DNA synthesis in these CD24(hi) proliferative
cells. In this study, we also report down-regulation of the
multipotency marker, Oct4 within the above defined subset of
cells. This may have deleterious effects on normal brain
development.
Having observed that CD24(hi) cells were extensively infected
and had decreased ability to proliferate, we then sought to identify
the effect of viral infection on cells that are down-stream of CD24-
expressing neuronal precursors. Our analysis for intracellular
DCX, a marker for young neurons, was found to be significantly
down-regulated in virus-infected brains. DCX plays an important
role in signaling for neuronal migration during brain development
and is a marker of early migratory neuroblasts. DCX haploinsuf-
ficiency can lead to various degrees of mental retardation, the
extent of retardation is linked to the quantity of arrested neurons
in the white matter [44,45]. This has been previously reported in
in vitro studies using human neural stem/precursor cells that were
infected with CMV, the DCX expression was down-regulated,
shown at both mRNA and protein levels [46]. On the other hand,
we did not observe any change in the expression levels of
intracellular GFAP, a marker for astrocytes. HCMV infection of
neural progenitor cells in the undifferentiated stage down-
regulated GFAP expression while it remained unaltered following
infection after differentiation [46]. Further validation of prolifer-
ation arrest in neuronal precursor cells and reduced DCX
expression with progressive infection was obtained from decreased
expression of neurotrophins, such as BDNF and NT3. The
activities of BDNF are pleiotropic and include protection from
neural apoptosis, enhanced neuronal proliferation, increased
granular neuron migration, and long-term potentiation [47,48].
Down-regulation of the gene encoding of the neurotrophin NT3
was also associated with viral brain infection.
Infection of different resident cells of the CNS and loss of
neuroepithelial cells secondary to lytic infection have also been
reported [49,50]. Although MCMV targets several other cell types
in the developing brain, NSCs in particular bear the brunt of virus
infection. In conclusion, we found that MCMV brain infection of
new born mice causes significant loss of NSCs, decreased
proliferation of neuronal precursor cells and loss of young neurons
expressing DCX. This neuronal loss was associated with down-
regulation of multipotency marker, Oct4 and neurotrophins,
indicating abnormal brain development.
Materials and Methods
Ethical statement
The animal use protocols used were approved by the University
of Minnesota Institutional Animal Care and Use Committee
(Protocol Number: 0807A40181).
Virus and animals
A recombinant MCMV that expresses green fluorescent protein
(GFP) under control of the human elongation factor-1a promoter,
inserted at the immediate-early gene (IE2) site (strain K181 MC.55
[ie2
2 GFP
+]) was kindly provided by Jon Reuter [50,51]. 200
TCID50 of virulent, salivary gland–passaged, sucrose gradient–
purified virus was used for all intracerebral (i.c.) infections. The
GFP-expressing virus was expanded on NIH 3T3 mouse
fibroblasts and purified by centrifugation over a sucrose cushion.
Mice were purchased from The Jackson Laboratory or Charles
River Corporation. Mating pairs were setup and carefully
monitored each day until they gave birth. All animals were
maintained in a specific pathogen–free facility.
Intracerebral infection of neonatal mice
Intracerebral infection of neonatal mice was performed as
previously described [52]. Briefly, neonatal mice were placed on
Figure 8. MCMV brain infection of the neonates down-
regulates neurotrphin expression levels. BDNF and NT3 mRNA
expression was assessed using quantitative real-time RT-PCR on total
RNA extracted from whole brain homogenates of control and virus-
infected neonates at 7 d p.i. mRNA levels were normalized to HPRT and
are presented as mean 6 SD normalized expression from pooled data
obtained using 3–5 animals per group from 2 independent exper-
iments.
doi:10.1371/journal.pone.0016211.g008
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cooled, stereotaxic frame (Stoelting) maintained at 4uCt o8 uCb ya
dry ice/ethanol reservoir. A 10 mL syringe (Hamilton Company)
fitted with a 30 gauge hypodermic needle (Hamilton Company)
was used to inject virus (200 TCID50 in 2 ml) or saline into the
right lateral cerebral lobe. No incision was made for injection. The
neonatal skull was penetrated with the needle for all injections.
Preparation of single cell preparation from neonatal
brains and flow cytometry
Entire brain tissues obtained from control and infected neonates
at 7 d p.i. were dissociated into single cell suspension as using
previously described methods [10]. Briefly, tissue samples were
gently minced using a scalpel and were resuspended in a purified
trypsin-like replacement in Dulbecco’s PBS/EDTA (TrypLE
Select; Invitrogen; containing 200 units/mL DNase I (Roche)
and 1 mM MgCl2. We also used the enzyme papain (12 units/
mL; Worthington, Lakewood, NJ) in experiments that involved
staining for CD133. The enzyme papain was preactivated in
1.1 mM EDTA, 0.067 mM mercaptoethanol, and 5.5 mM
cysteine-HCl for 30 min before addition. The absence of
bicarbonate in the HBSS allowed dissections and incubations to
be performed in a room atmosphere. Samples were placed in a
37uC water bath for 30 min during digestion. Samples were then
spun at 2006g for 5 min, resuspended in fresh HBSS/DNase/
MgCl2 without enzyme, and filtered using cell strainers (40 mm).
Cells were counted by trypan blue dye exclusion method, 1610
6
cells from both control and infected brains were used for flow
cytometric analysis.
For flow cytometry, cells were resuspended in flow cytometry
buffer, consisting of 16PBS, pH 7.2, containing 2% fetal bovine
serum. Cells were counted and diluted to a density of 10
6 cells per
milliliter. For surface marker analysis, cells were stained with anti-
mouse cell surface markers for 30 min at 4uC. Antibodies used
were, CD133-APC or PE (Miltenyi Biotec Inc, Auburn, CA),
CD15-APC or PE (ebiosciences, San Diego, CA), CD24-PE-Cy7,
CD45-PE-Cy5, CD29-PE (BD Biosciences, San Jose, CA). For
staining intracellular markers, cells were surface stained, prior to
fixation and permeabalization using Cytofix/Cytoperm (BD
Biosciences, San Jose, CA). Surface markers were selected based
on the experiment being performed: nestin-PE or APC (R&D
Systems, Minneapolis, MN and BD Biosciences, San Jose, CA),
DCX, GFAP-PE (Santa Cruz Biotechnology, Santa Cruz, CA)
and Oct4-APC (R&D Systems, Minneapolis, MN). Cells were
washed in staining buffer, and then secondary fluorescent-
conjugated antibody (if needed) was added at the appropriate
dilution and incubated on ice for 30 min. Cells were analyzed on a
FACSCanto flow cytometer (BD Biosciences). Background
fluorescence was measured using unlabeled cells and cells labeled
with isotype control or secondary antibody alone; and used to set
gating parameters between positive and negative cell populations.
Cell aggregates and small debris were excluded from analysis or
isolation on the basis of side scatter and forward scatter; dead cells
(7 AAD+) and CD45-PE-Cy5+ immune cells were excluded from
analysis. The data collected were analyzed using FlowJo software
(TreeStar).
BrdU labeling and detection of BrdU+ cells by flow
cytometry
BrdU labeling of neonatal mice was done as described
previously [53], MCMV-infected or control newborn mice were
injected intraperitoneally with BrdU (50 mg/g body weight) 7 d
after infection. Mice were killed at 24 h after BrdU administration.
Single cell suspension was prepared from control and infected
brains as described earlier. Cells were surface stained with CD24-
PE-Cy7 and CD29-PE, and with CD133-APC. Intranuclear BrdU
was stained using the FITC BrdU Flow Kit (BD Biosciences San
Jose, CA). Interference of MCMV-GFP signal with FITC BrdU
was ruled out as repeated fixing and permeablization during the
staining protocol dampened the GFP signal from virus-infected
cells, this was confirmed on simultaneously treated cells by
fluorescent microscopy for GFP signal prior to staining with BrdU-
FITC. The cells were fixed and permeablized by resuspending in
100 mL of Cytofix/Cytoperm (BD Biosciences) buffer at room
temperature for 30 min, followed by the addition of 1 mL of wash
buffer (BD Biosciences). The samples were spun at 3006g for
5 min and the supernatant was aspirated. The cells were then
resuspended in 100 ml of Cytoperm Plus buffer (BD Biosciences)
on ice for 10 min. After washing and centrifuging, the cells were
resuspended in 100 ml of Cytofix/Cytoperm buffer at room
temperature for 5 min. The cells were then resuspended in 100 mL
of DNAse (30 mg; stock from kit was diluted in PBS (Ca
2+/Mg
2+
free) containing 0.1 mM CaCl2 and 10 mM MgCl2) in a dry heat
block at 37uC for 1 h. Following washing and centrifuging, the
cells were resuspended in 50 ml of FITC-conjugated anti-BrdU
(1:50 dilution) in the dark, at room temperature for 20 min. After
the samples were washed, they were resuspended with 20 ml of the
nuclear marker, 7-AAD, at room temperature in the dark. The
cells were then resuspended in 1 mL of staining buffer (PBS, 3%
FBS, 0.09% sodium azide). Prior to analysis, cells were filtered
through a cell strainer cap (30 mm) to remove debris. The data was
collected the same day on a BD FACSCanto system. The data
collected was analyzed using FlowJo software (TreeStar).
Real-time PCR for BDNF and NT3
Total RNA was extracted from brain tissue homogenates with
Trizol reagent (Invitrogen, Carlsbad, CA). One mg RNA was
DNase (Ambion, Applied Biosystems, Austin, TX) treated and
reverse transcribed to cDNA with SuperScript
TM III (Invitrogen),
dNTP (GE Healthcare, Piscataway, NJ) and oligo (dT)12–18
(Promega, Madison, WI). Real-time PCR was performed in
Mx3000p (Stratagene, La Jolla, CA) with SYBR Advantage qPCR
Premix (Clontech, Mountain View, CA), primers and cDNA
according to manufacturer’s protocol. Reaction conditions for
qPCR were as follows: initial denaturation at 95uC for 15 sec,
amplification for 40 cycles at 95uC for 10 sec, 60uC for 10 sec and
72uC for 10 sec followed by dissociation curve analysis (1 cycle at
95uC for 60 sec, 55uC for 30 sec and 95uC for 30 sec) to verify
PCR product specificity. Primer sequences used were: sense 59-
GGTATCCAAAGGCCAACTGA-39 and antisense 59-CTTAT-
GAATCGCCAGCCAAT-39 for BDNF; sense 59- CCAGGCG-
GATATCTTGAAAA-39 and antisense 59-AGCGTCTCT-
GTTGCCGTAGT –39 for NT3; sense 59-TGCTCGAGATGT-
CATGAAGG-39 and antisense 59-AATCCAGCAGGTCAG-
CAAAG-39, for hypoxanthine guanine phosphoribosyl transferase
(HPRT)-1 as housekeeping gene. After normalizing to HPRT-1
expression (DCt=target gene Ct2HPRT Ct) and then to control
group (DDCt=treatment DCt2C DCt), relative quantification
using 2‘2DDCt was calculated as fold change of target mRNA
expression vs. control.
Supporting Information
Figure S1 Periventricular cells are preferentially infected.
Coronal sections from neonatal brains showing GFP-expressing
cells indicative of viral infection with recombinant MCMV at 7 d
p.i. A. Lower magnifications demonstrate that MCMV is localized
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showing GFP+ cells stained for nucleus (DAPI).
(TIFF)
Figure S2 Neonatal mice fail to control viral brain infection.
Day-old littermates were injected intracranially with MCMV (500
or 200 TCID50 in 2 ml) or with saline. The infected and control
neonates were nourished in identical conditions. Data are
expressed as percent survival in each group at the indicated time
point, followed over the 15 d time-course of the experiment.
(TIFF)
Figure S3 Experimental model simulates congenital cytomega-
lovirus infection. Embryos from timed breeders were collected at
ED14.5 and brains were dissected out to prepare single cell
suspension. Cells were also prepared from brains harvested from
7 d old neonates. Cells were surface stained for CD24 and also for
intracellular nestin. Representative dotplot and histogram showing
ratios of CD24(hi) cells and percent of maximum cells expressing
nestin from both A. ED14.5 and B. P7 brains are shown. No
significant difference in the expression levels of CD24 and nestin
was observed between the groups analyzed. Data are derived from
two independent experiments, n=3–5 embryos/neonates.
(TIFF)
Figure S4 Immune responses to MCMV brain infection
predominantly consist of macrophages. At 7 d p.i., leukocytes
were isolated from MCMV-infected neonatal brains. Brain tissues
harvested from 4–6 animals were minced finely in RPMI (2 g/L
D-glucose and 10mM HEPES) and mechanically disrupted (in
Ca/Mg free HBSS) at room temperature for 20 min. Single cell
preparations from infected brains were resuspended in 30%
Percoll and banded on a 70% Percoll cushion at 9006ga t1 5 uC.
Brain leukocytes obtained from the 30–70% Percoll interface were
stained with anti-mouse immune cell surface markers for 45 min
at 4uC (CD45-PE-Cy7, CD11b-APC-CY7, Ly-6G-FITC, MHC
Class II- PE, F4/80-APC, CD4-FITC and CD8-PE BD
Biosciences, San Jose, CA, multiple set of analyses were performed
to accommodate different combination of markers with fluoro-
chromes) and analyzed by flow cytometry using a BD FACS-
Canto. Live leukocytes were gated using forward scatter and side
scatter parameters and analyzed using FlowJo software (TreeStar,
Inc.). A. We identified four distinct populations as shown. B.
Histogram showing F4/80+ cells from CD45(hi)CD11b(hi) cells.
C. Histogram showing MHC class II+ cells, indicating microglial
activation from CD45(int)CD11b(+). D. Dotplot showing ratio of
CD4 and CD8 from CD45(hi)CD11b(2) and from
CD45(hi)CD11b(+).
(TIFF)
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